Life Sciences Times, Author at Life Sciences Times

Cellino CEO Nabiha Saklayen Named EY’s Entrepreneur Of The Year 2025 for New England

June 13, 2025

Parallel Bio Raises $21 Million to Advance Human-Based Drug Discovery, Partners with Centivax on Universal Flu Vaccine

June 13, 2025

athenahealth, Humana, and Your Health Recognized for Reducing Care Gaps and Streamlining Clinician Workflows

June 12, 2025

THIS WEEK'S STORIES

Termeer Institute Launches New Chapter to Advance Patient-Centered Leadership in Life Sciences

June 12, 2025

Qlaris Bio Advances Fixed-Dose Combination Therapy for Glaucoma Treatment

June 11, 2025

Fable Therapeutics Appoints Dr. David J. Baker as Chief Scientific Officer to Lead Scientific Strategy and Pipeline Advancement

June 9, 2025

ABOUT US

Life Science Times is New England’s premier life sciences publication, covering the Pharma, Biotech, MedTech and Public Health sectors nationwide with a special focus on New England. Updated daily, we cover the latest news in everything else that touches any rubric of the rapidly growing life sciences industry.

Life Sciences Times

TOP AUTHORS

Most Read

Robotic Pet Startup Tombot Raises $6.1 Million to Launch Therapeutic Companion for Seniors

FDA Approves Merck’s Keytruda for Perioperative Use in Certain Head and Neck Cancer Patients

Cellino CEO Nabiha Saklayen Named EY’s Entrepreneur Of The Year 2025 for New England

Astria Therapeutics Reports Strong Long-Term Results for Navenibart in Hereditary Angioedema Patients

EDITOR PICKS

Cellino CEO Nabiha Saklayen Named EY’s Entrepreneur Of The Year 2025 for New England

Parallel Bio Raises $21 Million to Advance Human-Based Drug Discovery, Partners with Centivax on Universal Flu Vaccine

athenahealth, Humana, and Your Health Recognized for Reducing Care Gaps and Streamlining Clinician Workflows

THIS WEEK'S STORIES

Termeer Institute Launches New Chapter to Advance Patient-Centered Leadership in Life Sciences

Qlaris Bio Advances Fixed-Dose Combination Therapy for Glaucoma Treatment

Fable Therapeutics Appoints Dr. David J. Baker as Chief Scientific Officer to Lead Scientific Strategy and Pipeline Advancement

POPULAR CATEGORY

ABOUT US

FOLLOW US